Pharmaceutical

The Telmisartan and Hydrochlorothiazide Drug market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Telmisartan and Hydrochlorothiazide Drug is projected to grow fro…

• SKU :

  SAC2058060
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Galantamine Hydrobromide Lycoremine market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Galantamine Hydrobromide Lycoremine is projected to grow from US$ xx m…

• SKU :

  SAC2058045
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Parathyroid Hormone Analog market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Parathyroid Hormone Analog is projected to grow from US$ xx million in 2021, an…

• SKU :

  SAC2058019
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Anti-Venom market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Anti-Venom is projected to grow from US$ xx million in 2021, and is projected to reach xx by 20…

• SKU :

  SAC2058015
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Overactive Bladder Drug market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Overactive Bladder Drug is projected to grow from US$ xx million in 2021, and is p…

• SKU :

  SAC2058013
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Acute Intermittent Porphyria Drugs market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Acute Intermittent Porphyria Drugs is projected to grow from US$ xx mil…

• SKU :

  SAC2058012
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The HS3S1 Antibody market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for HS3S1 Antibody is projected to grow from US$ xx million in 2021, and is projected to reach …

• SKU :

  SAC2058000
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Magaldrate market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Magaldrate is projected to grow from US$ xx million in 2021, and is projected to reach xx by 20…

• SKU :

  SAC2057996
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Epidermal Growth Factor (EGF) market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Epidermal Growth Factor (EGF) is projected to grow from US$ xx million in 20…

• SKU :

  SAC2057981
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The rhEPO market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for rhEPO is projected to grow from US$ xx million in 2021, and is projected to reach xx by 2030, at a C…

• SKU :

  SAC2057930
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Nattokinase Supplement market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Nattokinase Supplement is projected to grow from US$ xx million in 2021, and is pro…

• SKU :

  SAC2057907
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Clindamycin phosphate Injection market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Clindamycin phosphate Injection is projected to grow from US$ xx million i…

• SKU :

  SAC2057905
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Tiagabine HCl market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Tiagabine HCl is projected to grow from US$ xx million in 2021, and is projected to reach xx…

• SKU :

  SAC2057881
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Acral Lentiginous Melanoma Drugs market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Acral Lentiginous Melanoma Drugs is projected to grow from US$ xx million…

• SKU :

  SAC2057828
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Estradiol Transdermal Patches market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Estradiol Transdermal Patches is projected to grow from US$ xx million in 20…

• SKU :

  SAC2057807
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0